Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

COSCIENS Biopharma Inc > AEZS's test vs. the clonidine and an arginine test
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(113)
•••
Comment by prophetoffactzon Jun 23, 2024 2:19pm
64 Views
Post# 36102357

RE:AEZS's test vs. the clonidine and an arginine test

RE:AEZS's test vs. the clonidine and an arginine testPerplexity Ai:

The Macimorelin stimulation test is an orally administered test that takes approximately 90 minutes to complete, with blood samples taken at intervals of 30, 45, 60, and 90 minutes after administration.In contrast, the clonidine and arginine tests are more time-consuming and require intravenous administration:
  1. Clonidine Test: This test typically involves administering clonidine orally or intravenously and then taking blood samples at multiple intervals over a period of about 2 to 3 hours to measure growth hormone levels.
  2. Arginine Test: The arginine stimulation test involves an intravenous infusion of arginine, with blood samples taken at intervals over approximately 2 to 3 hours to assess growth hormone secretion.
Thus, both the clonidine and arginine tests generally take about 2 to 3 hours, making them longer than the Macimorelin test, which is completed in about 90 minutes.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities